Profusa (NVACW) Shares Outstanding (Diluted Average) (2021 - 2026)

Profusa (NVACW) reported Shares Outstanding (Diluted Average) of $1.7 million for Q1 2026, up 6431.91% on a YoY basis from $25844.0 in Q1 2025, and up 404.27% quarter-over-quarter from $334762.0 in Q4 2025.

Profusa (NVACW) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends

Profusa has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $1.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 6431.91% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 6431.91% YoY), and the FY2025 full-year result was $334762.0, up 1195.32% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $1.7 million, up from $334762.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $31.7 million in Q3 2025, with the low at $25844.0 in Q4 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $5.5 million across 5 years, with a median of $5.2 million in 2022.
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) sank 99.5% — and 2026, when it soared 6431.91%.
  • Profusa's Shares Outstanding (Diluted Average) stood at $5.2 million in 2022, then changed by 0.0% to $5.2 million in 2023, then slumped by 99.5% to $25844.0 in 2024, then soared by 1195.32% to $334762.0 in 2025, then jumped by 404.27% to $1.7 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $1.7 million (Q1 2026), $334762.0 (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.75 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 386.50 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 457.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Profusa - - - 1.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.69 Mn
Dec 31, 2025 334,762.00
Sep 30, 2025 31.73 Mn
Jun 30, 2025 5.19 Mn
Mar 31, 2025 25,844.00
Dec 31, 2024 25,844.00
Sep 30, 2024 1.94 Mn
Jun 30, 2024 5.19 Mn
Mar 31, 2024 5.19 Mn
Dec 31, 2023 5.19 Mn
Sep 30, 2023 5.19 Mn
Jun 30, 2023 5.19 Mn
Mar 31, 2023 5.19 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 5.19 Mn
Jun 30, 2022 5.19 Mn
Mar 31, 2022 5.19 Mn
Dec 31, 2021 4.17 Mn